|
Real-time Estimate
Cboe BZX
12:19:55 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 35.60 USD | -0.01% |
|
+1.87% | -14.94% |
| 09-25 | UBS Cuts Medline Price Target to $43 From $45, Maintains Buy Rating | MT |
| 09-15 | Medline Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 12:20 PM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 31.24B | |||||
| 169B | |||||
| 110B | |||||
| 106B | |||||
| 73.87B | |||||
| 58.98B |
- Stock Market
- Stocks
- MDLN Stock
- Charts Medline Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
